Immediate Impact
30 standout
Citing Papers
Reshaping the immune microenvironment and reversing immunosenescence by natural products: Prospects for immunotherapy in gastric cancer
2025 Standout
Nanomaterials-assisted photothermal therapy for breast cancer: State-of-the-art advances and future perspectives
2024 Standout
Works of Xinqun Chen being referenced
KEYNOTE-811 pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction cancer (mG/GEJc): A double-blind, randomized, placebo-controlled phase III study.
2020
KEYNOTE-811 pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction cancer (mG/GEJC): A double-blind, randomized, placebo-controlled phase 3 study.
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Xinqun Chen | 58 | 42 | 64 | 11 | 128 | |
| A.V. Guizard | 47 | 61 | 125 | 10 | 182 | |
| Rachel L. Kyllo | 28 | 36 | 60 | 10 | 183 | |
| Elena Resina | 51 | 45 | 28 | 15 | 185 | |
| Pascal Jonker | 74 | 34 | 26 | 13 | 175 | |
| Michiel de Maaker | 27 | 18 | 61 | 9 | 172 | |
| Umair Mahmood | 48 | 67 | 46 | 16 | 189 | |
| Kyle T. Bradley | 26 | 9 | 58 | 16 | 122 | |
| Jinlong Huang | 27 | 20 | 33 | 11 | 134 | |
| Maria Lucia Iacovino | 51 | 69 | 127 | 13 | 215 | |
| Carlijn van de Water | 38 | 42 | 67 | 11 | 141 |
All Works
Loading papers...